Skip to search formSkip to main contentSkip to account menu

AM 2233

Known as: AM-2233, AM2233 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
A Validated Method for the Detection of Synthetic Cannabinoids in Oral Fluid.
Workplace drug testing in Australia is governed by two standards AS/NZS 4308:2008 for testing in urine and AS 4760:2006 for oral… 
2016
2016
Determination of a selection of synthetic cannabinoids and metabolites in urine by UHPSFC-MS/MS and by UHPLC-MS/MS.
Two different analytical techniques, ultra-high performance supercritical fluid chromatography-tandem mass spectrometry (UHPSFC… 
2013
2013
In vitro metabolic studies of AM 2233 and JWH-210 , novel synthetic cannabinoids
The smoking of “herbal mixtures” as an alternative to the cannabis-based products has become an issue not only in the social… 
Review
2012
Review
2012
Identification and quantitation of JWH-213, a cannabimimetic indole, as a designer drug in a herbal product
In our survey of designer drugs in the Japanese market, a cannabimimetic indole was identified as a new active compound in a… 
Review
2012
Review
2012
Analysis of azepane isomers of AM-2233 and AM-1220, and detection of an inhibitor of fatty acid amide hydrolase [3′-(aminocarbonyl)(1,1′-biphenyl)-3-yl]-cyclohexylcarbamate (URB597) obtained as…
During our careful survey of unregulated drugs from November 2011 to January 2012 in the Tokyo area, we found two new compounds… 
2012
2012
The requirement of Smad4 in Mouse Early Embryonic Development
Highly Cited
2011
Highly Cited
2011
Identification of a novel cannabimimetic phenylacetylindole, cannabipiperidiethanone, as a designer drug in a herbal product and its affinity for cannabinoid CB₁ and CB₂ receptors.
A new cannabimimetic phenylacetylindole (cannabipiperidiethanone, 1) has been found as an adulterant in a herbal product which… 
2006
2006
F200A substitution in the third transmembrane helix of human cannabinoid CB1 receptor converts AM2233 from receptor agonist to inverse agonist.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)